These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35337138)

  • 21. Update on human African trypanosomiasis (sleeping sickness).
    Kennedy PGE
    J Neurol; 2019 Sep; 266(9):2334-2337. PubMed ID: 31209574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human African trypanosomiasis.
    Lejon V; Bentivoglio M; Franco JR
    Handb Clin Neurol; 2013; 114():169-81. PubMed ID: 23829907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural naphthoquinones and their derivatives as potential drug molecules against trypanosome parasites.
    Rani R; Sethi K; Kumar S; Varma RS; Kumar R
    Chem Biol Drug Des; 2022 Dec; 100(6):786-817. PubMed ID: 35852920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei.
    Sun YN; No JH; Lee GY; Li W; Yang SY; Yang G; Schmidt TJ; Kang JS; Kim YH
    Molecules; 2016 Apr; 21(4):480. PubMed ID: 27077842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites.
    Devine W; Thomas SM; Erath J; Bachovchin KA; Lee PJ; Leed SE; Rodriguez A; Sciotti RJ; Mensa-Wilmot K; Pollastri MP
    ACS Med Chem Lett; 2017 Mar; 8(3):350-354. PubMed ID: 28337329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal and Wash-Out Studies Identify Medicines for Malaria Venture Pathogen Box Compounds with Fast-Acting Activity against Both
    Sykes ML; Kennedy EK; Read KD; Kaiser M; Avery VM
    Microorganisms; 2022 Jun; 10(7):. PubMed ID: 35889006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.
    Bastos IM; Motta FN; Grellier P; Santana JM
    Curr Med Chem; 2013; 20(25):3103-15. PubMed ID: 23514419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness.
    Abdeen S; Salim N; Mammadova N; Summers CM; Goldsmith-Pestana K; McMahon-Pratt D; Schultz PG; Horwich AL; Chapman E; Johnson SM
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5247-5253. PubMed ID: 27720295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review on the diagnosis of animal trypanosomoses.
    Desquesnes M; Gonzatti M; Sazmand A; Thévenon S; Bossard G; Boulangé A; Gimonneau G; Truc P; Herder S; Ravel S; Sereno D; Jamonneau V; Jittapalapong S; Jacquiet P; Solano P; Berthier D
    Parasit Vectors; 2022 Feb; 15(1):64. PubMed ID: 35183235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-leishmanial and anti-trypanosomal natural products from endophytes.
    Hzounda Fokou JB; Dize D; Etame Loe GM; Nko'o MHJ; Ngene JP; Ngoule CC; Boyom FF
    Parasitol Res; 2021 Mar; 120(3):785-796. PubMed ID: 33409640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basic Biology of Trypanosoma brucei with Reference to the Development of Chemotherapies.
    Dean S
    Curr Pharm Des; 2021; 27(14):1650-1670. PubMed ID: 33463458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The continuing problem of human African trypanosomiasis (sleeping sickness).
    Kennedy PG
    Ann Neurol; 2008 Aug; 64(2):116-26. PubMed ID: 18756506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory diagnosis of trypanosomiasis.
    Cattand P; de Raadt P
    Clin Lab Med; 1991 Dec; 11(4):899-908. PubMed ID: 1802527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness).
    Kennedy PG
    Lancet Neurol; 2013 Feb; 12(2):186-94. PubMed ID: 23260189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas disease.
    Witschel M; Rottmann M; Kaiser M; Brun R
    PLoS Negl Trop Dis; 2012; 6(10):e1805. PubMed ID: 23145187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.
    Lepesheva GI; Waterman MR
    Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Atypical human trypanosomoses].
    Truc P; Nzoumbou-Boko R; Desquesnes M; Semballa S; Vincendeau P
    Med Sante Trop; 2014; 24(3):249-52. PubMed ID: 24918468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bis(2-aminoimidazolines) and Bisguanidines: Synthetic Approaches, Antiparasitic Activity and DNA Binding Properties.
    Dardonville C; Martínez JJN
    Curr Med Chem; 2017; 24(33):3606-3632. PubMed ID: 28641558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Treatments to Control African Trypanosomiasis and One Health Perspective.
    Venturelli A; Tagliazucchi L; Lima C; Venuti F; Malpezzi G; Magoulas GE; Santarem N; Calogeropoulou T; Cordeiro-da-Silva A; Costi MP
    Microorganisms; 2022 Jun; 10(7):. PubMed ID: 35889018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.